EU Projects


The EANM is engaging in several European-funded projects. Check them below!

EU Projects


Funding stream: EU4Health

Duration: 18 months (2022-2023)

Partners: ECO, OECI, ESSO, SIOG, EFIC, ESP, Tartu University Hospital, ESGO, EUSOMA, ESTRO, EASL, University of Cyprus, Institut Curie, ESSM, APSCO, Heidelberg University, University Politecnica de Valencia, Trinity College Dublin, EONS, EATEL, EAPC, ESO, Champalimaud Foundation, ESPEN, University of Ljubljana, NCI, EASO, EANM, University College Dublin, ELF, Medical University of Gdansk, EAU 

EANM’s role: Consortium Member 

Scope and objectives:

  • As part of the Europe’s Beating Cancer Plan, INTERACT-EUROPE has brought together 33 partners from 17 countries aiming at developing a European inter-specialty cancer training programme involving all main oncology disciplines and professions, cancer centres and patient groups, based on relevant needs assessments.
  • The project has fostered a patient-centric approach to quality cancer care through the promotion of multi-disciplinary and multi-professional team working.

Main deliverables: 



Funding stream: EU4Health

Duration: 36 months (2023-2026)

Partners: 38 partners including ECO, Heidelberg University, ESSO, Wien Medical University, ESTRO, ESO, Graz Medical University, EANM, Health Assessment Europe, EAPC, ESP, EONS, Complex Oncology Centre, Institut Curie, ESOP, SIOPE, Wonca etc.

EANM’s role: Consortium member 

Scope & objectives: As the second phase of the EU co-funded project for an Inter-Specialty Cancer Training Programme (ISCTP), INTERACT-EUROPE 100 is an ambitious project to provide cancer care professionals with the training necessary to enhance multidisciplinary collaboration – now bringing the ISCTP to 100 cancer centres across Europe, building on the work of INTERACT-EUROPE.

Interested Cancer Centres: visit the INTERACT-EUROPE website to sign up


Co-funded by the European Union. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or the European Health and Digital Executive Agency (HaDEA). Neither the European Union nor the granting authority can be held responsible for them.

Erasmus+ RLT Academy

Funding stream: ERASMUS+

Duration: 24 months (2022-2024)

Partners: KU Leuven, Policlinico Gemelli, I.R.S.T. Meldola, European Association of Urology, University of Duisburg-Essen, Eberhard Karl, University of Tübingen, Centre Léon Bérard, Hospital Sant Pau, Semmelweis University, Andcode, EANM

EANM’s role: Consortium Member (Work Package 2 Lead)

Scope & objectives:

  • The RLT Academy project aims to launch a multidisciplinary and transnational blended education programme for healthcare professionals on the use of radioligand therapies in cancer care.
  • The RLT Academy project will launch specialised training programmes on radioligand therapies for healthcare professionals in Europe and globally.
  • The project will contribute to greater adoption of RLTs across Europe (and the world) by closing the capacity gap and allowing healthcare professionals to establish and expand RLT services.

Main deliverables: